MULTIPLE SCLEROSIS
Clinical trials for MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug tested in kids with MS after other treatments fail
Disease control TerminatedThis study tested a drug called alemtuzumab in children and teenagers (ages 10-17) with relapsing multiple sclerosis (MS) whose disease was still active despite being on other standard MS medications. The goal was to see if switching to alemtuzumab could better control their MS b…
Matched conditions: MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
MS drug trial halted after failing main goal
Disease control TerminatedThis study tested an oral drug called SAR443820 to see if it could reduce nerve damage in people with multiple sclerosis (MS). About 174 adults with different types of MS took either the drug or a placebo for nearly a year. The trial was stopped early because the drug did not mee…
Matched conditions: MULTIPLE SCLEROSIS
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Swallow sensor trial halted after failing to match gold standard
Diagnosis TerminatedThis study tested a new device called the Dysphagia Detection System (DDS), which is a small sensor worn on the neck. Researchers wanted to see if it could accurately detect unsafe or inefficient swallowing in people with conditions like stroke, Parkinson's, and dementia, compare…
Matched conditions: MULTIPLE SCLEROSIS
Phase: NA • Sponsor: Société des Produits Nestlé (SPN) • Aim: Diagnosis
Last updated Mar 16, 2026 15:25 UTC
-
Could a common MS drug also fight debilitating fatigue?
Symptom relief TerminatedThis study aimed to see if starting the multiple sclerosis (MS) medication ozanimod could reduce the severe fatigue many patients experience. Researchers observed 26 adults with MS for three months, using smartphone apps and activity trackers to measure fatigue, mood, and sleep. …
Matched conditions: MULTIPLE SCLEROSIS
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Electrical stimulation tested to restore MS Patients' sense of touch
Symptom relief TerminatedThis study tested a hand rehabilitation program for people with multiple sclerosis (MS) who have lost feeling in their hands. It used a gentle electrical stimulation device (TENS) along with hand exercises, aiming to improve touch sensitivity and make daily tasks easier. The goal…
Matched conditions: MULTIPLE SCLEROSIS
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC
-
Brain scans may reveal MS Drug's effectiveness sooner
Knowledge-focused TerminatedThis study aimed to see if a special type of MRI scan could detect early changes in the brain that predict how well the MS drug Tysabri works over two years. Researchers followed 70 patients with relapsing-remitting MS who were starting Tysabri treatment. They compared detailed M…
Matched conditions: MULTIPLE SCLEROSIS
Phase: PHASE4 • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Wearable tech tries to track MS progression
Knowledge-focused TerminatedThis study tested a wearable device called Syde® to see if it could reliably track changes in walking and movement in people with multiple sclerosis (MS). Researchers compared the device's data to standard clinical tests performed in a doctor's office every six months for two yea…
Matched conditions: MULTIPLE SCLEROSIS
Sponsor: SYSNAV • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC